Jesus L. Gil-Garcia
Girona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Categorizing and characterizing intestinal dysbiosis: evaluating stool microbial test clinical utility.
Journal: Frontiers in microbiomes
Published: October 16, 2024
Clinical performance study of a fecal bacterial signature test for colorectal cancer screening.
Journal: PloS one
Published: June 09, 2023
Definition of a microbial signature as a predictor of endoscopic post-surgical recurrence in patients with Crohn's disease.
Journal: Frontiers in molecular medicine
Published: September 16, 2022
RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment.
Journal: Inflammatory bowel diseases
Published: September 28, 2021
A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and Metabolic Activity of Butyrate-Producing Bacteria in Faecal Samples.
Journal: Frontiers in microbiology
Published: December 10, 2020
Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers.
Journal: Alimentary pharmacology & therapeutics
Published: April 09, 2018
Daily thanatomicrobiome changes in soil as an approach of postmortem interval estimation: An ecological perspective.
Journal: Forensic science international
Published: January 18, 2017
Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn's Disease.
Journal: Journal of Crohn's & colitis
Published: December 18, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026